CopyFind
APO-DEFERASIROX
medicine 📍 CA

APO-DEFERASIROX

Analogs of APO-DEFERASIROX

Find cheaper analogs and generic equivalents for APO-DEFERASIROX.

Ingredients

Active Ingredient: DEFERASIROX


Product Overview

About APO-DEFERASIROX

APO-DEFERASIROX is a prescription medication containing the active ingredient Deferasirox, a chelating agent used to treat iron overload in patients with certain medical conditions.

Key Benefits & Uses

  • Treatment of iron overload in patients with transfusion-dependent thalassemia and other anemias.
  • Management of iron overload in patients with sickle cell disease.
  • Reduction of iron stores in patients with non-transfusion-dependent thalassemia.

Active Ingredient & Action

Deferasirox works by binding to iron in the body and promoting its excretion through the feces, thereby reducing iron stores and preventing further accumulation.

Important Notes

APO-DEFERASIROX should only be used under the guidance of a healthcare professional. It is essential to follow the recommended dosage and administration schedule to minimize the risk of adverse effects. Patients with kidney disease or other underlying medical conditions should be closely monitored while taking APO-DEFERASIROX.

Visitor ratings

Help others by rating how useful this product page is.

No ratings yet — be the first.

Similar Products & Analogs

ЗЕНО

Active: Deferasirox

Match: 100% Compare →
Exjade

Active: deferasirox

Match: 100% Compare →
Jadenu

Active: Deferasirox

Match: 100% Compare →
ЕКСІДЖАД

Active: Deferasirox

Match: 100% Compare →
Тип Джей

Active: Deferasirox

Match: 100% Compare →
Deferasirox

Active: Deferasirox

Match: 100% Compare →
Jadenu Sprinkle

Active: Deferasirox

Match: 100% Compare →
PMS-DEFERASIROX

Active: DEFERASIROX

Match: 100% Compare →
TARO-DEFERASIROX

Active: DEFERASIROX

Match: 100% Compare →
Deferasirox Mylan

Active: deferasirox

Match: 100% Compare →
Deferasirox Accord

Active: deferasirox

Match: 100% Compare →
Desirox 500 Tablet

Active: Deferasirox

Match: 100% Compare →